Wild-type (senile) amyloidosis epidemiology and demographics: Difference between revisions
No edit summary |
|||
| Line 31: | Line 31: | ||
=== Gender === | === Gender === | ||
* Men are traditionally more commonly affected by wild-type (senile) amyloidosis than women. | * Men are traditionally more commonly affected by wild-type (senile) amyloidosis than women.<ref>{{Cite journal | ||
| author = [[Belinda Ng]], [[Lawreen H. Connors]], [[Ravin Davidoff]], [[Martha Skinner]] & [[Rodney H. Falk]] | |||
| title = Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis | |||
| journal = [[Archives of internal medicine]] | |||
| volume = 165 | |||
| issue = 12 | |||
| pages = 1425–1429 | |||
| year = 2005 | |||
| month = June | |||
| doi = 10.1001/archinte.165.12.1425 | |||
| pmid = 15983293 | |||
}}</ref> | |||
==References== | ==References== | ||
Revision as of 18:14, 17 December 2019
|
Wild-type (senile) amyloidosis Microchapters |
|
Differentiating Wild-type (senile) amyloidosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Wild-type (senile) amyloidosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Wild-type (senile) amyloidosis epidemiology and demographics |
|
FDA on Wild-type (senile) amyloidosis epidemiology and demographics |
|
CDC on Wild-type (senile) amyloidosis epidemiology and demographics |
|
Wild-type (senile) amyloidosis epidemiology and demographics in the news |
|
Blogs on Wild-type (senile) amyloidosis epidemiology and demographics |
|
Risk calculators and risk factors for Wild-type (senile) amyloidosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]
Overview
The incidence of amyloidosis is approximately 1.2 per 100,000 individuals per year worldwide. The actual incidence of wild-type (senile) amyloidosis in particular is unknown. he mortality rate of systemic amyloidosis is approximately 100 per 100,000 deaths in developed countries. Patients with wild-type (senile) amyloidosis are almost always elderly (65 years of age or older). There is no racial predilection to wild-type (senile) amyloidosis. Men are traditionally more commonly affected by wild-type (senile) amyloidosis than women.
Epidemiology and Demographics
Incidence
- The incidence of amyloidosis is approximately 1.2 per 100,000 individuals per year worldwide.[1]
- The actual incidence of wild-type (senile) amyloidosis in particular is unknown.
Prevalence
- The prevalence of wild-type (senile) amyloidosis has not been determined.
Mortality rate
- The mortality rate of systemic amyloidosis is approximately 100 per 100,000 deaths in developed countries.[2]
Age
- Patients with wild-type (senile) amyloidosis are almost always elderly (65 years of age or older).
Race
- There is no racial predilection to wild-type (senile) amyloidosis.
Gender
- Men are traditionally more commonly affected by wild-type (senile) amyloidosis than women.[3]
References
- ↑ Khan MF, Falk RH (November 2001). "Amyloidosis". Postgrad Med J. 77 (913): 686–93. PMC 1742163. PMID 11677276.
- ↑ Pepys MB (2006). "Amyloidosis". Annu. Rev. Med. 57: 223–41. doi:10.1146/annurev.med.57.121304.131243. PMID 16409147.
- ↑ Belinda Ng, Lawreen H. Connors, Ravin Davidoff, Martha Skinner & Rodney H. Falk (2005). "Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis". Archives of internal medicine. 165 (12): 1425–1429. doi:10.1001/archinte.165.12.1425. PMID 15983293. Unknown parameter
|month=ignored (help)